High AIM2 inflammasomes scores showed a bad prognosis in GBM, KIRC, KIRP, LGG, PAAD, PRAD, THYM, and UVM and were hazard factors for patients (all P < 0.05) (Figure 7C). This evidence concerns the gene AIM2 and glioblastoma.